Sign up today for 26th July webinar, to hear CTO Gordon McInroy PhD discuss rapid active protein access using the eProtein Discovery system https://t.co/n4ziE1x2IN #proteinexpression#solubleprotein
We are honored and delighted to welcome synthetic biology leader Professor Michael Jewett as a distinguished member to our Scientific Advisory Board! Dr. Jewett brings Nuclera subject matter expertise on harnessing cell free protein synthesis technologies
https://t.co/JFsGtzriU5
We're delighted to announce that we received the @businessweekly Tech Scale-up of the Year Award. 2022 has brought our eProtein bioprinter into select labs enabling their access to proteins which is a key milestone on our path to our launch. https://t.co/jUE6eCeW3r
We are so thrilled to have Dr. Colin Barnes on our Executive Leadership Team as our VP of Intellectual Property. Read more about Colin's career and his pivotal role in the commercialization of early sequencing technology.
https://t.co/ApsFjsZ0Gj
Proteins are key for drug discovery. The startup @nuclera has worked on bringing a desktop 3D protein printer to market since 2013, to help scientists do their research. Now with a €38m raise, it can do it. @AmadeusCapital@EInk#Biotechnology@siftedeu https://t.co/pkLSQX7nht
Tired of the endless cloning and protein expression experiments?
Come and join our exciting team at @nuclera 🌟🌟
We are looking for a Synthetic Biologist to help developing our desktop bioprinter: DNA to proteins within a day 😱
https://t.co/P9QLHV4rMG
Warm congratulations to Prof Shankar Balasubramanian for winning the 2021 Breakthrough prize for next-generation sequencing. Shankar is a scientific mentor to our very own Michael & Gordon. https://t.co/DLkhDJ2v4I
With the right team and today’s technology, there are no limitations. @Nuclera and @EInk have made biology accessible together through digital microfluidics. https://t.co/GzDIIc6VTX
Did you hear about our work with @nuclera on a desktop protein and gene “bioprinter?” We just wrote a #blog on the topic, so hop in here to learn more: https://t.co/ZikOFvENI4
Now on Clubhouse, we have Michael Chen of @nuclera, which is combining enzymatic DNA synthesis, digital microfluidics, and protein synthesis in a desktop bioprinter. They are on a mission to make biology more accessible. Join the discussion now!
#synbio
https://t.co/AqEXKwFgBT